July 29, 2016 6:57 AM ET

Pharmaceuticals

Company Overview of Elcelyx Therapeutics, Inc.

Key Executives for Elcelyx Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Alain D. Baron M.D.16 RelationshipsChief Executive Officer, President, Member of Management Board and Director62
Martin R. Brown No RelationshipsSenior Vice President of Finance & Operations69
Mark Fineman Ph.D.No RelationshipsSenior Vice President of R&D--
Thomas Bicsak Ph.D.No RelationshipsVice President of Regulatory Affairs & Quality Assurance--

Elcelyx Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ralph E. Christoffersen Ph.D., J.D. 68 RelationshipsGalleon Pharmaceuticals, Inc.78
Alain D. Baron M.D. 16 RelationshipsElcelyx Therapeutics, Inc.62
James W. Glasheen Ph.D. 32 RelationshipsTechnology Partners49
Ginger L. Graham 114 RelationshipsWalgreens Boots Alliance, Inc.60
Richard Jon Barry 14 RelationshipsSarepta Therapeutics, Inc.57
View All Board Members

Elcelyx Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
436.6K
Bonus
531.9K
Total Short Term Compensation
642.8K
Total Value of Options
20.5M
Compensation as of Fiscal Year
Elcelyx Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Recce Limited Establishes Head Office at L34, 50 Bridge Street Sydney; Announces Executive Appointments
July 27, 2016 11:45 PM ET
RPG Life Sciences Limited Announces Management Changes
July 27, 2016 11:01 AM ET
Eli Lilly and Company Announces Management Changes
July 27, 2016 10:45 AM ET
Anuh Pharma Ltd. Announces Resignation of Gulabchand Sharda as Non-Executive Director
July 27, 2016 9:24 AM ET
BTG plc Announces the Appointment of Graham Hetherington as a Non-Executive Director of the Board and Chair of the Audit Committee, Effective from 1 August, 2016
July 27, 2016 6:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Elcelyx Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.